A Monllor-Tormos, A García-Vigara, O Morgan, M-Á García-Pérez, J J Tarín, A Cano
{"title":"Allelic variants of the estrogen receptor genes and frailty phenotype in postmenopausal women.","authors":"A Monllor-Tormos, A García-Vigara, O Morgan, M-Á García-Pérez, J J Tarín, A Cano","doi":"10.1080/13697137.2024.2306269","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The prevalence of frailty has been related to menopause. Our main objective was to investigate whether single nucleotide polymorphisms (SNPs) of the estrogen receptor (ER) <i>ER</i><math><mi>α</mi></math> and <i>ER</i><math><mrow><mi>β</mi></mrow></math> genes were related to the frailty phenotype in a population of community-dwelling postmenopausal women.</p><p><strong>Methods: </strong>A cross-sectional study was performed in which we selected five SNPs, three in the <i>ER</i><math><mrow><mi>α</mi></mrow></math> gene and two in the <i>ER</i><math><mrow><mi>β</mi></mrow></math>. Linear regression was used to estimate the percentage of phenotypic variance after adjusting for confounding variables.</p><p><strong>Results: </strong>A total of 470 women (mean ± standard deviation age 63.83 ± 8.16 years) were included, of whom 137 women were frail. The SNP rs3798577 of the <i>ER</i><math><mrow><mi>α</mi></mrow></math> gene was the only variant associated with frailty, but this significance faded in the multivariant analysis. Body mass index (<i>p</i> = 0.012), number of comorbidities (0 vs. ≥2, <i>p</i> = 0.002) and two reproductive variables, number of miscarriages (none vs. ≥2, <i>p</i> = 0.036) and of childbirths (one vs. ≥3, <i>p</i> = 0.008), were independently related to frailty.</p><p><strong>Conclusion: </strong>The five SNPs of the <i>ER</i><math><mrow><mi>α</mi></mrow></math> and <i>ER</i><math><mrow><mi>β</mi></mrow></math> genes tested were not correlated with frailty. Other SNPs of the ER warrant analysis to clarify whether variance in the gene response affects frailty status.</p>","PeriodicalId":10213,"journal":{"name":"Climacteric","volume":" ","pages":"314-320"},"PeriodicalIF":2.9000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Climacteric","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13697137.2024.2306269","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The prevalence of frailty has been related to menopause. Our main objective was to investigate whether single nucleotide polymorphisms (SNPs) of the estrogen receptor (ER) ER and ER genes were related to the frailty phenotype in a population of community-dwelling postmenopausal women.
Methods: A cross-sectional study was performed in which we selected five SNPs, three in the ER gene and two in the ER. Linear regression was used to estimate the percentage of phenotypic variance after adjusting for confounding variables.
Results: A total of 470 women (mean ± standard deviation age 63.83 ± 8.16 years) were included, of whom 137 women were frail. The SNP rs3798577 of the ER gene was the only variant associated with frailty, but this significance faded in the multivariant analysis. Body mass index (p = 0.012), number of comorbidities (0 vs. ≥2, p = 0.002) and two reproductive variables, number of miscarriages (none vs. ≥2, p = 0.036) and of childbirths (one vs. ≥3, p = 0.008), were independently related to frailty.
Conclusion: The five SNPs of the ER and ER genes tested were not correlated with frailty. Other SNPs of the ER warrant analysis to clarify whether variance in the gene response affects frailty status.
期刊介绍:
Climacteric is the official journal of the International Menopause Society (IMS). As an international peer-reviewed journal it publishes original research and reviews of all aspects of aging in women.
Climacteric was founded by the IMS in 1998 and today has become a leading journal in the publication of peer-reviewed papers on the menopause, climacteric and mid-life health. Topics covered include endocrine changes, symptoms attributed to the menopause and their treatment, hormone replacement and alternative therapies, lifestyles, and the counselling and education of peri- and postmenopausal women. Climacteric, published bimonthly, also features regular invited reviews, editorials and commentaries on recent developments.
The editorial review board of Climacteric includes leading scientific and clinical experts in the field of midlife medicine and research and is headed by its Editor-in-Chief, Professor Rod Baber of Australia. He and his team of Associate Editors act independently to set a clear editorial policy, co-ordinate peer review, and ensure a rapid response to submitted papers.